Showing results (541-550 of 816) with videos related to

Sort By:
Pageof 82
Blood Cancer Journal|February 13, 2016
Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trialJ J Shah, L Feng, S K Thomas, et al.
Blood|June 15, 1994
BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapyJ Q Guo, J Y Lian, Y M Xian, et al.
Transplantation|August 1, 1985
Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisoloneH J Deeg, T P Loughran, R Storb, et al.
Blood|July 1, 1990
Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantationJ Nemunaitis, J W Singer, C D Buckner, et al.
Blood|September 1, 1990
What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?R Storb, M Pepe, C Anasetti, et al.
Blood|January 1, 1993
Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiationF G Schuening, F R Appelbaum, H J Deeg, et al.
Transplantation|February 1, 1984
Recovery of in vivo cellular immunity after human marrow grafting. Influence of time postgrafting and acute graft-versus-host diseaseR P Witherspoon, D Matthews, R Storb, et al.
Leukemia Research|January 1, 1982
Allogeneic marrow transplantation for patients with acute non-lymphoblastic leukemia in second remissionC D Buckner, R A Clift, E D Thomas, et al.
Blood|February 1, 1988
Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trialsR Storb, H J Deeg, L Fisher, et al.
Experimental Hematology|August 1, 1980
Canine lymphocyte subpopulationsK Atkinson, H J Deeg, R Storb, et al.
Pageof 82